Seronegative Sjögren Syndrome: A Forgotten Entity?

J Rheumatol. 2023 Oct 15:jrheum.2023-0247. doi: 10.3899/jrheum.2023-0247. Online ahead of print.

Abstract

As a highly varied disease, Sjögren syndrome (SS; also termed Sjögren disease) is estimated to affect 0.01% to 0.72% of the population, with an overwhelming bias toward the female gender.1 SS causes a significant burden to the quality of life of patients and inhibits their function.

Publication types

  • Editorial